Analysis of nicotinamide mononucleotide (NMN) and Urolithin A supplements revealed a wide range in levels of the active ingredients compared to label claims, indicating “a considerable disparity in the quality of geroprotective supplements."
Swiss longevity biotech company Timeline (parent company Amazentis) announced that it has raised CHF 56 million (US$ 66 million) in an oversubscribed Series D financing round that included strategic investments by L’Oréal and Nestlé.
A pharmacokinetics study published in the Journal of Pharmaceutical and Biomedical Analysis provides a closer look at how potent phenolic compounds in a standardized pomegranate extract are metabolized by gut microbiota to confer health benefits.
Some dietary supplements on Amazon showing urolithin A on their label do not contain any of the cellular aging ingredient, alleges a new analysis by Timeline (formerly Amazentis) shared with NutraIngredients-USA.
Urolithin A (UA) appears to alter the gut microbiota by improving its diversity, according to Japanese scientists, who link this modest effect with improvements to vascular endothelial function.
An investigation into the effect of urolithin A (UA) on mitophagy and mitochondrial function in knee joint cells shows supplementation improved mitochondrial health and had positive effects on joint function and mobility in both healthy and osteoarthritis...
A placebo-controlled, randomised clinical trial has indicated that urolithin A supplementation has a positive impact on skeletal muscle performance and mitochondrial health among an older population.
Swiss life sciences company Amazentis has combined Mitopure (urolithin A) with high protein to increase sports performance, recovery, and overall cellular health.